Diuretics: a contemporary pharmacological classification?

MCA Kehrenberg, HS Bachmann - Naunyn-schmiedeberg's Archives of …, 2022 - Springer
Diuretics are drugs that increase the flow of urine. They are commonly used to treat edema,
hypertension, and heart failure. Typically, the pharmacological group consists of five …

[HTML][HTML] High-throughput screening as a drug repurposing strategy for poor outcome subgroups of pediatric B-cell precursor Acute Lymphoblastic Leukemia

A Oikonomou, L Valsecchi, M Quadri, T Watrin… - Biochemical …, 2023 - Elsevier
Although a great cure rate has been achieved for pediatric BCP-ALL, approximately 15% of
patients do not respond to conventional chemotherapy and experience disease relapse. A …

Understanding membrane protein drug targets in computational perspective

J Gong, Y Chen, F Pu, P Sun, F He, L Zhang… - Current Drug …, 2019 - ingentaconnect.com
Membrane proteins play crucial physiological roles in vivo and are the major category of
drug targets for pharmaceuticals. The research on membrane protein is a significant part in …

SPHK1 is a novel target of metformin in ovarian cancer

PC Hart, T Chiyoda, X Liu, M Weigert, M Curtis… - Molecular Cancer …, 2019 - AACR
The role of phospholipid signaling in ovarian cancer is poorly understood. Sphingosine-1-
phosphate (S1P) is a bioactive metabolite of sphingosine that has been associated with …

The allergic rhinitis and its impact on asthma (ARIA) approach of value-added medicines: As-needed treatment in allergic rhinitis

J Bousquet, M Toumi, B Sousa-Pinto, JM Anto… - The Journal of Allergy …, 2022 - Elsevier
Drug repurposing is a major field of value-added medicine. It involves investigating and
evaluating existing drugs for new therapeutic purposes that address unmet healthcare …

Biomimetic metal-organic nanoparticles prepared with a 3D-printed microfluidic device as a novel formulation for disulfiram-based therapy against breast cancer

Y Chang, J Jiang, W Chen, W Yang, L Chen… - Applied materials …, 2020 - Elsevier
Disulfiram (DSF) is currently tested in several clinical trials for cancer treatment in
combination with copper (Cu) ions. Usually, DSF and Cu are administered in two separate …

The antipsychotic chlorpromazine suppresses YAP signaling, stemness properties, and drug resistance in breast cancer cells

CE Yang, WY Lee, HW Cheng, CH Chung, FL Mi… - Chemico-biological …, 2019 - Elsevier
The major obstacle in current cancer therapy is the existence of cancer stem cells (CSCs),
which are responsible for therapeutic resistance and contribute to metastasis and …

Zafirlukast inhibits the growth of lung adenocarcinoma via inhibiting TMEM16A channel activity

S Shi, B Ma, F Sun, C Qu, G Li, D Shi, W Liu… - Journal of Biological …, 2022 - ASBMB
Lung cancer has the highest mortality among cancers worldwide due to its high incidence
and lack of the effective cures. We have previously demonstrated that the membrane ion …

Targeting the Tumor Extracellular Matrix by the Natural Molecule 4-Methylumbelliferone: A Complementary and Alternative Cancer Therapeutic Strategy

DL Vitale, A Icardi, P Rosales, FM Spinelli… - Frontiers in …, 2021 - frontiersin.org
In antineoplastic therapy, one of the challenges is to adjust the treatment to the needs of
each patient and reduce the toxicity caused by conventional antitumor strategies. It has been …

Ligand and Structure-Based In Silico Determination of the Most Promising SARS-CoV-2 nsp16-nsp10 2′-o-Methyltransferase Complex Inhibitors among 3009 FDA …

IH Eissa, MS Alesawy, AM Saleh, EB Elkaeed… - Molecules, 2022 - mdpi.com
As a continuation of our earlier work against SARS-CoV-2, seven FDA-approved drugs were
designated as the best SARS-CoV-2 nsp16-nsp10 2′-o-methyltransferase (2′ OMTase) …